Mingzhi Zhang Selected Research

Mingzhi Zhang Research Topics

Disease

79	Neoplasms (Cancer) 10/2022 - 05/2009
36	Lymphoma (Lymphomas) 10/2022 - 09/2011
21	T-Cell Lymphoma (Lymphoma, T Cell) 10/2022 - 05/2004
20	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 04/2013
15	Hypertension (High Blood Pressure) 01/2022 - 04/2011
10	Inflammation (Inflammations) 06/2021 - 03/2012
9	Obesity 01/2022 - 04/2014
8	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 11/2013
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 11/2015
7	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2009
6	Carcinogenesis 09/2022 - 02/2015
6	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 11/2015
6	Myopia 07/2021 - 08/2011
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2016
6	Refractive Errors (Refractive Error) 01/2021 - 12/2007
6	Glioma (Gliomas) 12/2019 - 08/2015
5	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 11/2018
5	Extranodal NK-T-Cell Lymphoma 01/2022 - 11/2014
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021 - 03/2016
5	Glaucoma 03/2020 - 02/2010
5	Carcinoma (Carcinomatosis) 01/2018 - 12/2014
4	Hodgkin Disease (Hodgkin's Disease) 07/2022 - 01/2017
4	Cataract (Cataracts) 07/2022 - 12/2007
4	Leukemia 06/2022 - 08/2015
4	Ischemic Stroke 06/2022 - 06/2014
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2013
4	Stroke (Strokes) 01/2022 - 07/2016
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 12/2014
4	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2013
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2015
4	Ganglion Cysts (Ganglion) 05/2019 - 01/2016
4	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 01/2013
4	Esophageal Squamous Cell Carcinoma 11/2018 - 02/2015
4	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2015 - 01/2012
3	Infections 01/2022 - 12/2014
3	Rhinitis 07/2021 - 08/2014
3	Astigmatism 07/2021 - 08/2011
3	Body Weight (Weight, Body) 04/2021 - 04/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2009
15	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2012
14	Gemcitabine FDA Link 01/2022 - 11/2014
14	Biomarkers (Surrogate Marker)IBA 11/2021 - 06/2013
14	Rituximab (Mabthera)FDA Link 10/2021 - 04/2013
13	Retinaldehyde (Retinal)IBA 01/2022 - 03/2008
13	Biological ProductsIBA 10/2020 - 02/2015
11	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 03/2012
10	LipidsIBA 01/2021 - 04/2011
9	pegaspargase (Oncaspar)FDA Link 01/2022 - 11/2014
9	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 02/2007
7	Chimeric Antigen ReceptorsIBA 06/2022 - 09/2015
7	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2017
7	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2011
7	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2011
7	Messenger RNA (mRNA)IBA 10/2019 - 02/2007
7	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2012
6	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 08/2014
6	Pharmaceutical PreparationsIBA 01/2021 - 11/2013
5	Circular RNAIBA 09/2022 - 11/2019
5	Natriuretic PeptidesIBA 06/2022 - 01/2020
5	Thalidomide (Thalomid)FDA Link 01/2022 - 01/2017
5	Monoclonal AntibodiesIBA 01/2022 - 08/2015
5	Long Noncoding RNAIBA 01/2021 - 09/2017
5	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2017
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2017
5	LigandsIBA 08/2020 - 04/2012
5	C-Reactive ProteinIBA 07/2019 - 06/2013
5	Pyruvic Acid (Pyruvate)IBA 02/2017 - 10/2015
4	ibrutinibIBA 01/2022 - 03/2016
4	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2015
4	FurinIBA 04/2021 - 11/2019
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2021 - 11/2015
4	Insulin (Novolin)FDA Link 01/2021 - 04/2011
4	AlbuminsIBA 10/2020 - 01/2018
4	AntigensIBA 08/2020 - 09/2015
4	Oxidoreductases (Dehydrogenase)IBA 02/2017 - 10/2015
4	Small Interfering RNA (siRNA)IBA 02/2015 - 01/2012
3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2020
3	Asparaginase (Elspar)FDA Link 01/2022 - 01/2017
3	N-propionylprocainamideIBA 01/2022 - 01/2020
3	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2022 - 01/2020
3	Uric Acid (Urate)IBA 01/2022 - 01/2020
3	Atrial Natriuretic Factor (ANF)IBA 01/2022 - 01/2020
3	CateninsIBA 10/2021 - 05/2009
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2021 - 09/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2021 - 01/2017
3	Methotrexate (Mexate)FDA LinkGeneric 06/2021 - 11/2013
3	EnzymesIBA 06/2021 - 08/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2018
3	apatinibIBA 12/2020 - 03/2018
3	CytokinesIBA 08/2020 - 12/2014
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017

Therapy/Procedure

34	Therapeutics 06/2022 - 12/2010
27	Drug Therapy (Chemotherapy) 01/2022 - 05/2013
10	Immunotherapy 07/2022 - 09/2015
9	Radiotherapy 01/2022 - 11/2013
4	Eyeglasses (Spectacles) 08/2011 - 12/2008
3	Intraocular Lenses (Intraocular Lens) 01/2021 - 12/2007